[2,2′-Bipyridine]-4,4′-dicarboxylic acid – (6813-38-3)

1707-68-2, 2, 2'-bis(2-chlorophenyl)-4, 4', 5, 5'-tetraphenyl-1, 1'-biimidazole, 1, 1'-Bi-1H-imidazole, 2, 2'-bis(2-chlorophenyl)-4, 4', 5, 5'-tetraphenyl-, EINECS 216-952-7, 2-(2-chlorophenyl)-1-[2-(2-chlorophenyl)-4, 5-diphenylimidazol-1-yl]-4, 5-diphenylimidazole, 2, 2'-Bis(2-chlorophenyl)-4, 4', 5, 5'-tetraphenyl-1, 1'-bi-1H-imidazole, DTXSID3061895, 1, 1'-Bi-1H-imidazole, 2, 2'-bis(chlorophenyl)-4, 4', 5, 5'-tetraphenyl-, MFCD00060081, 1, 1'-Biimidazole, 2, 2'-bis(o-chlorophenyl)-4, 4', 5, 5'-tetraphenyl-, VOKXCKZXSBBOPC-UHFFFAOYSA-N, A7F5M8MB5X, SCHEMBL63728, DTXCID5035458, AKOS022173277, SY284376, B4032, CS-0186475, NS00047658, F17030, 2, 2'-bis(2-chlorophenyl)-4, 4', 5, 5'-tetraphenyl-1, 1'-bi-1h imidazole, 2, 2/'-Bis(2-dichlorophenyl)-4, 4/'5, 5/'-tetraphenyl-1, 2/'-biimidazole, 2, 2 inverted exclamation mark -Bis(2-chlorophenyl)-4, 4 inverted exclamation mark, 5, 5 inverted exclamation mark -tetraphenyl-1, 1 inverted exclamation mark -biimidazole, 216-952-7